Muromonab-CD3
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Muromonab-CD3, covering 2010-09-09 to 2017-05-24. Get the full timeline:
Most recent: Clinical Trial Update: Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases [Phase 2]